Abstract: A memory device and a management method thereof are provided. The memory device includes a controller and at least one memory channel. The memory channel includes at least one memory chip. The at least one memory chip is commonly coupled to the controller through an interrupt signal wire. The at least one memory chip generates at least one local interrupt signal and performs a logic operation on the at least one local interrupt signal to generate a common interrupt signal. The interrupt signal wire is configured to transmit the common interrupt signal to the controller.

Abstract: Applications of butylidenephthalide (BP), comprising the use of BP in providing a kit for promoting differentiation of stem cells into brown adipose cells, and the use of BP in preparing a medicament, wherein the medicament is used for inhibiting the accumulation of white adipose cells, promoting the conversion of white adipose cells into brown adipose cells, inhibiting weight gain and/or reducing the content of triglycerides, glucose, and total cholesterol in blood.

Abstract: The present disclosure provides an iPSC cell derived from a somatic cell comprising a Cbx family gene and the applications thereof. Also provided are methods for generating the somatic cells that have potential to become induced pluripotent stem (iPS) cells (iPS cells) without oncogenic properties, and methods for generating iPS cells from the population of cells, which may then be used for transplantation and for cellular differentiation and interaction.

Abstract: Applications of butylidenephthalide (BP), comprising the use of BP in providing a kit for promoting differentiation of stem cells into brown adipose cells, and the use of BP in preparing a medicament, wherein the medicament is used for inhibiting the accumulation of white adipose cells, promoting the conversion of white adipose cells into brown adipose cells, inhibiting weight gain and/or reducing the content of triglycerides, glucose, and total cholesterol in blood.

Abstract: A signal transmission device, including a RF processing circuit and a cable connecting circuit including a first choke inductor, a first and second bypass capacitors, and a first coupling capacitor, is provided. One end of the first choke inductor is coupled to a transceiver end of a RF transceiver and the other end is coupled to a first control end of a RF antenna controller. The transceiver end is coupled to a first conductor. The first bypass capacitor is coupled between the other end and a digital ground terminal. The first coupling capacitor is coupled between the digital ground terminal and a RF ground terminal. The second conductor is coupled to the RF ground terminal and a second control terminal of the RF antenna controller at a second connecting end of a RF cable. The second bypass capacitor is coupled between the second control terminal and the digital ground terminal.

Abstract: A signal transmission device, including a RF processing circuit and a cable connecting circuit including a first choke inductor, a first and second bypass capacitors, and a first coupling capacitor, is provided. One end of the first choke inductor is coupled to a transceiver end of a RF transceiver and the other end is coupled to a first control end of a RF antenna controller. The transceiver end is coupled to a first conductor. The first bypass capacitor is coupled between the other end and a digital ground terminal. The first coupling capacitor is coupled between the digital ground terminal and a RF ground terminal. The second conductor is coupled to the RF ground terminal and a second control terminal of the RF antenna controller at a second connecting end of a RF cable. The second bypass capacitor is coupled between the second control terminal and the digital ground terminal.

Abstract: The present disclosure provides an iPSC cell derived from a somatic cell comprising a Cbx family gene and the applications thereof Also provided are methods for generating the somatic cells that have potential to become induced pluripotent stem (iPS) cells (iPS cells) without oncogenic properties, and methods for generating iPS cells from the population of cells, which may then be used for transplantation and for cellular differentiation and interaction.

Abstract: A method of establishing a paid connection between multi-platforms, where a transmitting end application is installed in a transmitting end apparatus of a sharing source and a receiving end application is installed in a receiving end apparatus of a sharing target. When establishing a connection, the transmitting end application/receiving end application confirms whether a unique ID of the receiving end apparatus/transmitting end apparatus exists in an exception list, and confirms whether the receiving end application/transmitting end apparatus makes payment based on an operating system used by the transmitting end apparatus/receiving end application, in order to determine establishing a limited or an unlimited connection between the transmitting end apparatus and the receiving end apparatus.

Abstract: A cell for treating neurodegenerative disease treated with angelica extract is provided. The pharmaceutical composition comprises the cell for treating neurodegenerative disease and can significantly increase and recover the number of dopaminergic neurons to achieve the goal for treating neurodegenerative disease.

Abstract: Applications of butylidenephthalide (BP), comprising the use of BP in providing a kit for promoting differentiation of stem cells into brown adipose cells, and the use of BP in preparing a medicament, wherein the medicament is used for inhibiting the accumulation of white adipose cells, promoting the conversion of white adipose cells into brown adipose cells, inhibiting weight gain and/or reducing the content of triglycerides, glucose, and total cholesterol in blood.

Abstract: A mirroring transmission method is provided. The present method retrieves image frames and audio signals of a transmitter and transmits the retrieved image frames and retrieved audio signals to a receiver to be displayed wirelessly. In the meantime, the present method monitors status of a network connected with the transmitter and the receiver, and determines if the network is stable or not. Also, the method stops retrieving and transmitting the audio signal from the transmitter to the receiver, and controls the transmitter to display the audio signal directly through an internal audio module whenever the network is determined unstable.

Abstract: A mirror display system having low data traffic comprises a transmitting-end device and a receiving-end device. The transmitting-end device stores a first file and transforms the first file into the first page images. The receiving-end device stores a second file with same content of the first file and transforms the second file into the second page images. The transmitting-end device selects one of the first page images according to a page-selecting operation, and transmits an identifying page data of the selected first page image to the receiving-end device. The receiving-end device selects and displays one of the second page images corresponding to the identifying page data. With pre-storing the file duplicate in the receiving-end device and the receiving-end automatically generating the image, the required data traffic of the mirror display is effectively reduced and the mirror display operation is made smoother.

Abstract: A cell for treating neurodegenerative disease treated with angelica extract is provided. The pharmaceutical composition comprises the cell for treating neurodegenerative disease and can significantly increase and recover the number of dopaminergic neurons to achieve the goal for treating neurodegenerative disease.

Abstract: A method of establishing a paid connection using a screen mirroring application between multi-platforms, where a transmitting end application is installed in a transmitting end apparatus of a sharing source and a receiving end application is installed in a receiving end apparatus of a sharing target. When establishing a connection, the transmitting end application confirms if an unique ID of the receiving end apparatus exists in an exception list, and if the receiving end application makes payment based on an operating system used by the transmitting end apparatus in order to determine establishing a limited or an unlimited connection between the transmitting end apparatus and the receiving end apparatus. Thus, the method assures that either the transmitting end application or the receiving end application is a paid version, a user complies with an application license agreement by using the exception list and the right of application developers is protected.

Abstract: A method for enhancing the therapeutic effect of a stem cell is provided. The method comprises treating the stem cell with ligustilide, wherein the treatment is conducted in a culture medium of the stem cell. A method of stem cell treatment is also provided, comprising administering to a subject in need an effective amount of a stem cell or a combination of ligustilide and a stem cell, wherein the stem cell has been treated with ligustilide.

Abstract: A method for enhancing the therapeutic effect of a stem cell on autoimmune diseases, cardiovascular diseases, and/or hematological diseases is provided. The method comprises treating the stem cell with ligustilide, wherein the treatment is conducted in a culture medium of the stem cell. A method of stem cell treatment is also provided, comprising administering to a subject suffering from autoimmune diseases, cardiovascular diseases, and/or hematological diseases an effective amount of a stem cell or a combination of ligustilide and a stem cell, wherein the stem cell has been treated with ligustilide.

Abstract: A method for enhancing the therapeutic effect of stem cells on autoimmune diseases, cardiovascular diseases, and/or hematological diseases is provided. The method comprises pre-treating the stem cells with ligustilide to increase the expression of differentiation-promoting genes in the stem cells, increase the expression of homing-promoting genes in the stem cells, and/or decrease the expression of inflammatory genes in the stem cells, wherein the treatment is conducted in a culture medium of the stem cell.

Abstract: A method for enhancing the therapeutic effect of a stem cell is provided. The method comprises treating the stem cell with ligustilide, wherein the treatment is conducted in a culture medium of the stem cell.

Abstract: A mirroring transmission method is provided. The present method retrieves image frames and audio signals of a transmitter and transmits the retrieved image frames and retrieved audio signals to a receiver to be displayed wirelessly. In the meantime, the present method monitors status of a network connected with the transmitter and the receiver, and determines if the network is stable or not. Also, the method stops retrieving and transmitting the audio signal from the transmitter to the receiver, and controls the transmitter to display the audio signal directly through an internal audio module whenever the network is determined unstable.

Abstract: A method for enhancing the therapeutic effect of stem cells on autoimmune diseases, cardiovascular diseases, and/or hematological diseases is provided. The method comprises pre-treating the stem cells with ligustilide to increase the expression of differentiation-promoting genes in the stem cells, increase the expression of homing-promoting genes in the stem cells, and/or decrease the expression of inflammatory genes in the stem cells, wherein the treatment is conducted in a culture medium of the stem cell.